Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China flag China · Delayed Price · Currency is CNY
4.050
-0.070 (-1.70%)
Apr 30, 2026, 3:00 PM CST

SHA:600594 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,2323,1222,8014,5064,3796,438
Market Cap Growth
14.40%11.44%-37.83%2.89%-31.98%55.75%
Enterprise Value
3,5403,5073,1754,9465,0096,897
Last Close Price
4.123.983.565.575.417.96
PE Ratio
---43.58-26.41
Forward PE
-19.1219.1219.1219.1219.12
PS Ratio
1.881.681.291.601.601.92
PB Ratio
1.441.381.081.491.371.81
P/TBV Ratio
1.751.671.371.891.742.74
P/FCF Ratio
12.5014.08-18.23195.7313.24
P/OCF Ratio
10.9812.1632.2511.9312.686.89
EV/Sales Ratio
2.061.881.461.751.832.06
EV/EBITDA Ratio
55.5249.83-14.7511.8911.88
EV/EBIT Ratio
---34.4020.0815.92
EV/FCF Ratio
13.7015.82-20.01223.8714.18
Debt / Equity Ratio
0.320.310.370.330.340.26
Debt / EBITDA Ratio
11.248.88-2.882.521.56
Debt / FCF Ratio
2.773.18-4.0148.581.88
Net Debt / Equity Ratio
0.100.110.160.100.160.15
Net Debt / EBITDA Ratio
4.123.66-5.470.871.170.92
Net Debt / FCF Ratio
0.871.16-43.491.1922.111.10
Asset Turnover
0.470.490.500.600.550.65
Inventory Turnover
1.241.301.431.541.381.42
Quick Ratio
1.010.941.171.561.171.03
Current Ratio
1.701.591.842.231.741.59
Return on Equity (ROE)
-14.59%-13.75%-11.90%2.94%-12.98%6.57%
Return on Assets (ROA)
-1.76%-1.55%-3.72%1.90%3.14%5.26%
Return on Invested Capital (ROIC)
-4.18%-3.38%-8.18%2.84%6.41%8.02%
Return on Capital Employed (ROCE)
-4.10%-3.70%-8.20%3.90%6.70%10.90%
Earnings Yield
-10.82%-10.56%-11.32%2.30%-9.74%3.79%
FCF Yield
8.00%7.10%-0.34%5.49%0.51%7.56%
Dividend Yield
---1.19%--
Payout Ratio
---39.82%-62.40%
Buyback Yield / Dilution
0.29%0.56%0.03%0.41%-0.14%0.01%
Total Shareholder Return
0.29%0.56%0.03%1.59%-0.14%0.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.